BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3734785)

  • 1. Characterization of a dopaminergic receptor that modulates adrenomedullary catecholamine release.
    González MC; Artalejo AR; Montiel C; Hervás PP; García AG
    J Neurochem; 1986 Aug; 47(2):382-8. PubMed ID: 3734785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dopaminergic receptor modulates catecholamine release from the cat adrenal gland.
    Artalejo AR; García AG; Montiel C; Sánchez-García P
    J Physiol; 1985 May; 362():359-68. PubMed ID: 4020691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptors on adrenal chromaffin cells modulate calcium uptake and catecholamine release.
    Bigornia L; Suozzo M; Ryan KA; Napp D; Schneider AS
    J Neurochem; 1988 Oct; 51(4):999-1006. PubMed ID: 2458437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dopaminergic receptor in adrenal medulla as a possible site of action for the droperidol-evoked hypertensive response.
    Montiel C; Artalejo AR; Bermejo PM; Sánchez-García P
    Anesthesiology; 1986 Nov; 65(5):474-9. PubMed ID: 3777477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells.
    Bigornia L; Allen CN; Jan CR; Lyon RA; Titeler M; Schneider AS
    J Pharmacol Exp Ther; 1990 Feb; 252(2):586-92. PubMed ID: 2156054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory mechanism of bromocriptine on catecholamine release evoked by cholinergic stimulation and membrane depolarization from the rat adrenal medulla.
    Lim DY; Lee YG; Kim IH
    Arch Pharm Res; 2002 Aug; 25(4):511-21. PubMed ID: 12214865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
    Quik M; Bergeron L; Mount H; Philie J
    Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells.
    Huettl P; Gerhardt GA; Browning MD; Masserano JM
    J Pharmacol Exp Ther; 1991 May; 257(2):567-74. PubMed ID: 1674528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory and radioligand binding studies on muscarinic receptors in bovine and feline chromaffin cells.
    Ballesta JJ; Borges R; García AG; Hidalgo MJ
    J Physiol; 1989 Nov; 418():411-26. PubMed ID: 2516125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
    Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization and autoradiographic localization of dopamine receptors in the rat adrenal medulla.
    Barili P; Zaccheo D; Amenta F
    Eur J Pharmacol; 1996 Aug; 310(2-3):129-35. PubMed ID: 8884208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apomorphine on adrenal medullary catecholamine levels.
    Montastruc JL; Gaillard G; Rascol O; Tran MA; Montastruc P
    Fundam Clin Pharmacol; 1989; 3(6):665-70. PubMed ID: 2575570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding.
    Lyon RA; Titeler M; Bigornia L; Schneider AS
    J Neurochem; 1987 Feb; 48(2):631-5. PubMed ID: 3794725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca(2+)-activated K+ channels modulate muscarinic secretion in cat chromaffin cells.
    Uceda G; Artalejo AR; López MG; Abad F; Neher E; García AG
    J Physiol; 1992 Aug; 454():213-30. PubMed ID: 1282156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anabasine on catecholamine secretion from the perfused rat adrenal medulla.
    Hong SP; Jeong MG; Lim DY
    J Cardiol; 2007 Dec; 50(6):351-62. PubMed ID: 18186309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of adrenomedullary catecholamine release by propranolol isomers and clonidine involving mechanisms unrelated to adrenoceptors.
    Orts A; Orellana C; Cantó T; Ceña V; González-García C; García AG
    Br J Pharmacol; 1987 Dec; 92(4):795-801. PubMed ID: 2827826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptor gene expression and binding sites in adrenal medulla and pheochromocytoma.
    Pupilli C; Lanzillotti R; Fiorelli G; Selli C; Gomez RA; Carey RM; Serio M; Mannelli M
    J Clin Endocrinol Metab; 1994 Jul; 79(1):56-61. PubMed ID: 8027253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N- and L-type calcium channel antagonists and (+/-)-Bay K8644 on nerve-induced catecholamine secretion from bovine perfused adrenal glands.
    O'Farrell M; Ziogas J; Marley PD
    Br J Pharmacol; 1997 Jun; 121(3):381-8. PubMed ID: 9179377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha- and beta-adrenoceptor agonists and antagonists on ATP and catecholamine release and desensitization of the nicotinic response in bovine adrenal chromaffin cells.
    Wan DC; Powis DA; Marley PD; Livett BG
    Biochem Pharmacol; 1988 Feb; 37(4):725-36. PubMed ID: 3342103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.